1. The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair
- Author
-
Shu-Ling Liu, Wei Li, Bei-Bei Zheng, Jing Wu, Junning Zhang, Yan Zhang, Meng-Dan Xu, Meng-Yao Wu, Fei-Ran Gong, and Min Tao
- Subjects
0301 basic medicine ,MAPK/ERK pathway ,Radiation-Sensitizing Agents ,Cell Survival ,DNA damage ,Endocrinology, Diabetes and Metabolism ,LIG1 ,Gene Expression Regulation, Enzymologic ,03 medical and health sciences ,XRCC1 ,chemistry.chemical_compound ,0302 clinical medicine ,Cell Line, Tumor ,Humans ,Medicine ,MTT assay ,Protein Phosphatase 2 ,Cell Proliferation ,Cantharidin ,Radiotherapy ,Hepatology ,Cell growth ,business.industry ,Cell Cycle ,Gastroenterology ,Cell cycle ,Gene Expression Regulation, Neoplastic ,Pancreatic Neoplasms ,030104 developmental biology ,chemistry ,030220 oncology & carcinogenesis ,Cancer research ,business ,Cell Division ,DNA Damage - Abstract
Background Cantharidin is an inhibitor of protein phosphatase 2 A (PP2A), and has been frequently used in clinical practice. In our previous study, we proved that cantharidin could arrest cell cycle in G2/M phase. Since cells at G2/M phase are sensitive to radiotherapy, in the present study, we investigated the radiotherapy-sesitization effect of cantharidin and the potential mechanisms involved. Methods Cell growth was determined by MTT assay. Cell cycle was evaluated by flow cytometry. DNA damage was visualized by phospho-Histone H2A.X staining. Expression of mRNA was tested by microarray assay and real-time PCR. Clinical information and RNA-Seq expression data were derived from The Cancer Genome Atlas (TCGA) pancreatic cancer cohort. Survival analysis was obtained by Kaplan-Meier estimates. Results Cantharidin strengthened the growth inhibition effect of irradiation. Cantharidin drove pancreatic cancer cells out of quiescent G0/G1 phase and arrested cell cycle in G2/M phase. As a result, cantharidin strengthened DNA damage which was induced by irradiation. Moreover, cantharidin repressed expressions of several genes participating in DNA damage repair, including UBE2T, RPA1, GTF2HH5, LIG1, POLD3, RMI2, XRCC1, PRKDC, FANC1, FAAP100, RAD50, RAD51D, RAD51B and DMC1, through JNK, ERK, PKC, p38 and/or NF-κB pathway dependent manners. Among these genes, worse overall survival for pancreatic cancer patients were associated with high mRNA expressions of POLD3, RMI2, PRKDC, FANC1, RAD50 and RAD51B, all of which could be down-regulated by cantharidin. Conclusion Cantharidin can sensitize pancreatic cancer cells to radiotherapy. Multiple mechanisms, including cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair, may be involved.
- Published
- 2018
- Full Text
- View/download PDF